Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis: A Post Hoc Analysis of 6 Randomized Clinical Trials

IMPORTANCE: Erythrodermic atopic dermatitis (AD) is a severe AD subtype defined by extensive skin involvement, leading to complications and sometimes hospitalization. OBJECTIVE: To assess dupilumab’s efficacy and safety in patients with erythrodermic AD in clinical trials. DESIGN, SETTING, AND PARTI...

Descripción completa

Detalles Bibliográficos
Autores principales: Paller, Amy S., Silverberg, Jonathan I., Cork, Michael J., Guttman-Yassky, Emma, Lockshin, Benjamin, Irvine, Alan D., Kim, Moon Bum, Kabashima, Kenji, Chen, Zhen, Lu, Yufang, Bansal, Ashish, Rossi, Ana B., Shabbir, Arsalan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018319/
https://www.ncbi.nlm.nih.gov/pubmed/36723913
http://dx.doi.org/10.1001/jamadermatol.2022.6192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018319/
https://www.ncbi.nlm.nih.gov/pubmed/36723913
http://dx.doi.org/10.1001/jamadermatol.2022.6192

Ejemplares similares